Alx Oncology Holdings (ALXO) Return on Capital Employed Growth (1y) (2021 - 2026)
Alx Oncology Holdings (ALXO) Return on Capital Employed Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 472.27 Bn | 467.47 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 122.18 Bn | 114.93 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.32 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 2,400.00 |
| 10 | Alx Oncology Holdings | 216.47 Mn | 216.47 Mn | - | 2,556.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,556.00 |
| Dec 31, 2025 | -12,841.00 |
| Sep 30, 2025 | -8,681.00 |
| Jun 30, 2025 | -3,320.00 |
| Mar 31, 2025 | -2,811.00 |
| Dec 31, 2024 | -893.00 |
| Sep 30, 2024 | -1,720.00 |
| Jun 30, 2024 | -4,668.00 |
| Mar 31, 2024 | -4,012.00 |
| Dec 31, 2023 | -4,227.00 |
| Sep 30, 2023 | -3,772.00 |
| Jun 30, 2023 | -2,268.00 |
| Mar 31, 2023 | -2,350.00 |
| Dec 31, 2022 | -2,261.00 |
| Sep 30, 2022 | -2,202.00 |
| Jun 30, 2022 | -1,965.00 |
| Mar 31, 2022 | -1,386.00 |
| Dec 31, 2021 | -957.00 |
| Sep 30, 2021 | 80.00 |